ENVESTNET ASSET MANAGEMENT INC

Position in KRYS — Krystal Biotech, Inc.

CIK 1407543 Berwyn, PA

Position in KRYS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,910,504

+$1,815,056 QoQ

Shares Held

13,212

+10.3% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#114

of 419 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. KRYS ranks #34 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	487,627	$242,218,959
2	REGN	Regeneron Pharmaceuticals, Inc.	109,838	$68,488,386
3	EXEL	Exelixis, Inc.	949,669	$51,671,490
4	ARGX	Argenx SE	55,346	$51,348,358
5	ALNY	Alnylam Pharmaceuticals, Inc.	136,395	$41,058,986
6	INSM	INSMED Inc	336,997	$35,930,620
7	RPRX	Royalty Pharma plc	513,096	$28,769,292
8	ROIV	Roivant Sciences Ltd.	713,946	$25,266,548

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,910,504	13,212	+10.3%	Shares	Sole	2026-08-03
2026-03-31	$3,095,448	11,983	+13.3%	Shares	Sole	2026-05-04
2025-12-31	$2,607,653	10,577	-19.3%	Shares	Sole	2026-02-10
2025-09-30	$2,313,955	13,108	-13.3%	Shares	Sole	2025-11-05
2025-06-30	$2,077,845	15,116	+21.9%	Shares	Sole	2025-08-01
2025-03-31	$2,235,539	12,399	+6.6%	Shares	Sole	2025-04-29
2024-12-31	$1,821,955	11,630	+1.1%	Shares	Sole	2025-02-13
2024-09-30	$2,094,983	11,509	+64.2%	Shares	Sole	2024-11-07
2024-06-30	$1,286,949	7,008	+56.7%	Shares	Sole	2024-08-08
2024-03-31	$795,880	4,473	+69.9%	Shares	Sole	2024-05-13
2023-12-31	$326,525	2,632	-27.7%	Shares	Sole	2024-02-13
2023-09-30	$422,008	3,638	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.